Silence Therapeutics (SLN) Current Assets (2019 - 2025)
Historic Current Assets for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $133.6 million.
- Silence Therapeutics' Current Assets fell 3470.39% to $133.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.6 million, marking a year-over-year decrease of 3470.39%. This contributed to the annual value of $187.4 million for FY2024, which is 8164.24% up from last year.
- Per Silence Therapeutics' latest filing, its Current Assets stood at $133.6 million for Q3 2025, which was down 3470.39% from $148.6 million recorded in Q2 2025.
- Silence Therapeutics' 5-year Current Assets high stood at $230.5 million for Q1 2024, and its period low was -$13.3 million during Q3 2021.
- For the 5-year period, Silence Therapeutics' Current Assets averaged around $132.6 million, with its median value being $122.0 million (2021).
- Its Current Assets has fluctuated over the past 5 years, first soared by 110761.81% in 2022, then tumbled by 3470.39% in 2025.
- Silence Therapeutics' Current Assets (Quarter) stood at $116.4 million in 2021, then dropped by 2.55% to $113.4 million in 2022, then fell by 11.33% to $100.6 million in 2023, then surged by 86.32% to $187.4 million in 2024, then dropped by 28.68% to $133.6 million in 2025.
- Its Current Assets stands at $133.6 million for Q3 2025, versus $148.6 million for Q2 2025 and $169.8 million for Q1 2025.